IRIS
IANNONE, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.459
AS - Asia 1.632
EU - Europa 1.311
SA - Sud America 388
Continente sconosciuto - Info sul continente non disponibili 338
AF - Africa 66
OC - Oceania 3
Totale 9.197
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.315
SG - Singapore 603
IT - Italia 424
CN - Cina 365
BR - Brasile 297
SE - Svezia 222
RU - Federazione Russa 212
HK - Hong Kong 185
VN - Vietnam 141
DE - Germania 127
GB - Regno Unito 88
BD - Bangladesh 69
FR - Francia 68
CA - Canada 62
IN - India 58
FI - Finlandia 46
ID - Indonesia 38
BE - Belgio 32
IQ - Iraq 27
AR - Argentina 24
TR - Turchia 21
MX - Messico 20
PL - Polonia 20
PK - Pakistan 18
CO - Colombia 17
EC - Ecuador 15
CI - Costa d'Avorio 14
JP - Giappone 14
UZ - Uzbekistan 14
ZA - Sudafrica 14
ES - Italia 13
GT - Guatemala 13
NL - Olanda 12
SA - Arabia Saudita 10
VE - Venezuela 10
CL - Cile 9
MA - Marocco 9
MY - Malesia 9
PH - Filippine 9
UA - Ucraina 9
AE - Emirati Arabi Uniti 8
GP - Guadalupe 7
IL - Israele 7
KE - Kenya 7
TN - Tunisia 7
AT - Austria 6
IE - Irlanda 6
NI - Nicaragua 6
PY - Paraguay 6
SV - El Salvador 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
CW - ???statistics.table.value.countryCode.CW??? 5
DZ - Algeria 5
EG - Egitto 5
HN - Honduras 5
RO - Romania 5
BO - Bolivia 4
CR - Costa Rica 4
KZ - Kazakistan 4
PE - Perù 4
PR - Porto Rico 4
TH - Thailandia 4
AU - Australia 3
BB - Barbados 3
BG - Bulgaria 3
EU - Europa 3
GR - Grecia 3
JM - Giamaica 3
JO - Giordania 3
LB - Libano 3
QA - Qatar 3
AL - Albania 2
DO - Repubblica Dominicana 2
EE - Estonia 2
KG - Kirghizistan 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HU - Ungheria 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LR - Liberia 1
MD - Moldavia 1
MK - Macedonia 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
Totale 8.862
Salva come PNG Salva come JPEG
Città #
Fairfield 558
Ashburn 551
Woodbridge 397
Singapore 341
Chandler 285
Houston 241
San Jose 228
Seattle 212
Ann Arbor 193
Cambridge 185
Hong Kong 183
Wilmington 183
Nyköping 182
Beijing 140
Dallas 140
Milan 136
New York 133
Council Bluffs 102
Los Angeles 86
Rome 55
Santa Clara 52
Nanjing 51
Roxbury 47
Lawrence 46
Bari 43
Lauterbourg 38
Inglewood 35
Brussels 32
Munich 32
Ho Chi Minh City 31
Brooklyn 27
Des Moines 27
Jacksonville 27
São Paulo 27
Hanoi 26
Dearborn 25
Jakarta 24
Columbus 23
Atlanta 22
Dong Ket 22
Helsinki 22
Boardman 20
Denver 20
Montreal 20
Frankfurt am Main 19
North Bergen 19
Princeton 19
Warsaw 18
The Dalles 16
Orem 15
San Diego 15
Abidjan 14
Buffalo 14
Phoenix 14
Chicago 13
San Francisco 13
Boston 12
London 12
Pune 12
Rio de Janeiro 12
Tokyo 12
Tashkent 11
Turin 11
Guatemala City 10
Haiphong 10
Medellín 10
Nanchang 10
Belo Horizonte 9
Bologna 9
Dhaka 9
Hebei 9
Johannesburg 9
Shanghai 9
Toronto 9
Falkenstein 8
Florence 8
Mexico City 8
Moscow 8
Naples 8
Shenyang 8
Baghdad 7
Chennai 7
Curitiba 7
Figino 7
Paris 7
Brasília 6
Guangzhou 6
Ha Long 6
Istanbul 6
Jiaxing 6
Kunming 6
Lahore 6
Maringá 6
Mumbai 6
Newark 6
Stockholm 6
Tampa 6
Tianjin 6
Zhengzhou 6
Baku 5
Totale 5.816
Salva come PNG Salva come JPEG
Nome #
Mesalazine for people with diverticular disease: A systematic review of randomized controlled trials 490
Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm 286
Concomitant and Bismuth Quadruple Therapy for Helicobacter pylori Eradication in Southern Italy: Preliminary Data from a Randomized Clinical Trial 254
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 231
Obesity as predictor of postoperative outcomes in liver transplant candidates: Review of the literature and future perspectives 222
Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population 218
Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors 218
Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy 211
Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model 207
Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients? 204
Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials 203
May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis? 198
Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement 179
Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease 176
The helper lymphocyte and mast cell immunohistochemical pattern in nonceliac gluten sensitivity 176
Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease 160
Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis 159
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 157
Inter-observer agreement of a new endoscopic score for ulcerative colitis activity: Preliminary experience 153
Helicobacter pylori primary and secondary genotypic resistance to clarithromycin and levofloxacin detection in stools: A 4-year scenario in Southern Italy 147
Predictivity of Autoimmune Stigmata for Gluten Sensitivity in Subjects with Microscopic Enteritis: A Retrospective Study 145
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 141
Liver stiffness and portal blood flow modifications induced by a liquid meal consumption: Pathogenetic mechanisms and clinical relevance 138
Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study 136
Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: What needs to be explored? 131
Acute pancreatitis in elderly patients: A retrospective evaluation at hospital admission 131
Silymarin, boswellic acid and curcumin enriched dietetic formulation reduces the growth of inherited intestinal polyps in an animal model 125
Escherichia coli Nissle 1917 in ulcerative colitis treatment: Systematic review and meta-analysis 122
Assessment of body composition: Intrinsic methodological limitations and statistical pitfalls 122
New fecal test for non-invasive Helicobacter pylori detection: A diagnostic accuracy study 118
Role of concomitant therapy for Helicobacter pylori eradication: A technical note 109
The spectrum of small intestinal lesions in patients with unexplained iron deficiency anemia detected by video capsule endoscopy 105
HCV-positive kidney transplant patients treated with direct-acting antivirals maintain stable medium-term graft function despite persistent reduction in tacrolimus trough levels 103
Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis 102
Trends of Liver Stiffness in Inflammatory Bowel Disease with Chronic Hepatitis C 101
null 100
Clinical outcomes associated with drugs for obesity and overweight: A systematic review and network meta-analysis of randomized controlled trials 98
Noninvasive molecular analysis of Helicobacter pylori: is it time for tailored first-line therapy? 97
Impact of Bifidobacterium longum Subspecies infantis on Pediatric Gut Health and Nutrition: Current Evidence and Future Directions 97
A prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection: A further confirmation of geographic Weight 96
Biological markers for non-celiac gluten sensitivity: A question awaiting for a convincing answer 96
Familial intestinal polyposis and device assisted enteroscopy: where do we stand? 91
null 90
Familial adenomatous polyposis small bowel surveillance: could indicators for video-capsule endoscopy be ascertained? 89
Natural History and Hepatitis B Virus Surface Antigen (HBsAg) Spontaneous Seroclearance in Hepatitis B Virus e-Antigen (HBeAg)-Negative Patients with Inactive Chronic Infection: A Multicenter Regional Study from South Italy 88
Epstein-Barr Virus-Related hyperacute hepatitis: May intravenous Ster-Oids be an effective approach? 87
Helicobacter pylori Secondary Antibiotic Resistance after One or More Eradication Failure: A Genotypic Stool Analysis Study 87
null 86
null 86
Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association 85
Sequential therapy for helicobacter pylori in elderly patients: Effectiveness, safety and predictors of success 83
Effect of Visual Booklets to Improve Bowel Preparation in Colonoscopy: Systematic Review with Meta-Analysis 82
null 82
null 81
null 81
null 80
null 79
null 79
Transmission electron microscopy helpfulness in Whipple's disease masked by immunosuppressant therapy for arthritis 77
null 74
Epithelial turnover in duodenal familial adenomatous polyposis: A possible role for estrogen receptors? 74
null 72
null 69
Novel frontiers of agents for bowel cleansing for colonoscopy 68
null 67
null 66
The Interaction Between Celiac Disease and Intestinal Microbiota 66
Letter: Could sequential therapy extended to 14 days replace prolonged triple regimens for Helicobacter pylori treatment? 64
null 59
null 59
Helicobacter pylori, liver cirrhosis, and portal hypertension: an updated appraisal 50
null 42
null 39
Seronegative Celiac Disease and immunoglobulin deficiency: Where to look in the submerged iceberg? 38
Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: how should rifabutin be managed in rescue regimens? 37
null 36
Pancreatic Cystic Lesions and Endoscopic Ultrasound Diagnostic Equipment: A Literature Review 17
null 13
Dieulafoy lesion of the gastrointestinal tract: what’s new? A narrative review 12
Totale 9.197
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.260
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.260
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022352 0 0 0 19 19 37 15 27 27 38 66 104
2022/2023695 87 115 59 57 56 104 9 84 90 4 16 14
2023/2024265 16 41 9 27 17 106 7 5 2 15 5 15
2024/20251.072 22 19 58 25 40 97 174 114 39 70 142 272
2025/20262.705 393 134 242 207 334 112 233 70 370 261 91 258
2026/20271.270 391 194 283 402 0 0 0 0 0 0 0 0
Totale 9.197